Business Context and Reporting Period
Company: AcelRx Pharmaceuticals, Inc. (Note: Request metadata listed "TALPHERA, INC." but the filing text identifies the registrant as AcelRx Pharmaceuticals, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: March 12, 2013
Reporting Period: Quarter and year ended December 31, 2012
This filing serves as a notification that the Company issued a press release on March 12, 2013, announcing its financial results for the specified period. The detailed financial data is contained in the press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover document for the 8-K filing and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms the announcement of results for the quarter and year ended December 31, 2012.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release containing the Company's financial results but does not include the text of that commentary.
Legal Disclaimer: The information in Item 2.02 and the accompanying press release is explicitly stated not to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into any other SEC filings.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) by reviewing Exhibit 99.1 (Press Release dated March 12, 2013), as they are not present in this summary text.
- Confirm the company name is AcelRx Pharmaceuticals, Inc., noting the discrepancy with the "TALPHERA, INC." label in the request metadata.
- Review the full press release for any forward-looking statements or guidance that may have been issued alongside the results.
- Note that the financial data in this specific 8-K item is not incorporated by reference into future filings.